MIR22HG is over-expressed in glioma and glioma stem-like cells. Its silencing constrains the Wnt/b-catenin axis via loss of miR-22-3p and -5p. This diminishes proliferation, invasion and tumor growth. This evidence concerns the gene MIR22HG and central nervous system cancer.